CDEK by Data4ThePeople
Sign in Sign up
← All organizations

CoTherix

For profitContributed to NME
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Jun 1, 2004

First marketed drug

Dec 29, 2004

First NDA

Dec 29, 2004

Last known activity

Apr 1, 2005

Acquired by Actelion → Johnson and Johnson on Nov 20, 2006

Timeline

2000s

  1. Jan 1, 2000

    CoTherix— Founded

  2. Dec 29, 2004

    iloprost— NDA Organization

  3. Nov 20, 2006

    Actelion— Acquired By

2010s

  1. Jun 16, 2017

    Johnson and Johnson— Now

Drugs by trial phase (1 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (2)

Details

Founded
San Francisco, CA, US Jan 1, 2000
First NDA
Dec 29, 2004
Last known activity
Apr 1, 2005

Designations held

  • Orphan drug
  • Priority review